| | Cancer | Skin Cancer
Vitiligo and Skin Cancer Risk: UV Vulnerability and Photoprotection Strategies
Elevated Risk Mechanism
Depigmented skin lacks melanin, the primary chromophore that absorbs and scatters UV radiation. This results in:
- Reduced minimal erythema dose (MED) → sunburn at lower UV exposure.
- Increased DNA damage (cyclobutane pyrimidine dimers) in keratinocytes.
- Impaired immune surveillance (Langerhans cell dysfunction in vitiliginous skin).
Epidemiologic Evidence
- Meta-analyses show 2–3 fold increased risk of melanoma and non-melanoma skin cancer (SCC, BCC) in vitiligo patients.
- Risk highest in: fair skin (Fitzpatrick I–II), extensive BSA involvement, history of phototherapy (PUVA > NB-UVB), immunosuppression.
- Paradox: Some studies suggest NB-UVB does not significantly increase SCC/BCC risk; PUVA does.
Photoprotection Protocol
- Broad-spectrum SPF 50+ daily (UVA-PF ≥1/3 SPF). Reapply 2-hourly outdoors.
- Photoprotective clothing: UPF 50+ shirts, wide-brim hats, UV-blocking sunglasses.
- Avoid peak UV: 10 AM – 4 PM (or when UV index ≥3).
- Shade-seeking behavior.
- No tanning beds.
Surveillance
- Annual total-body skin exam by dermatologist.
- Patient self-exam monthly (ABCDE for melanoma; new/changing lesions).
- Dermoscopy for equivocal lesions.
- Consider baseline photography for extensive vitiligo.
Special Considerations
- Phototherapy patients: Cumulative UV dose tracking; annual skin exam mandatory.
- Pediatric vitiligo: Lifelong UV protection critical; childhood sunburns strongly linked to melanoma.
- Repigmented skin: Remains UV-sensitive; continue protection.
Skin Cancer - Related Articles
- Understanding Skin Cancer: Beyond Melanoma
- Protecting Workers from Heat and Sun Exposure
- Pediatric Melanoma: Skin Cancer Can Occur at Age 11 – What Parents Should Know
- Cutaneous Anaplastic Large Cell Lymphoma (CALCL): Symptoms, Diagnosis & Treatment
- Recognizing Problematic Moles: When to See a Doctor
- CFLs and Skin Cancer Risk: Understanding UV Exposure
- Acrocyanosis: Causes, Symptoms, and Management of Blue Fingers and Toes
